循環器内科 Twitter アカウントlanguage English

英文原著論文 "2020" Original Papers in English

緑色のタイトル部分をクリックすると、論文PDFが表示されます。

【 2020 年 】（IF: 2019 年）

  1. Veronese G, Ammirati E, Brambatti M, Merlo M, Cipriani M, Potena L, Sormani P, Aoki T, Sugimura K, Sawamura A, Okumura T, Pinney S, Hong K, Shah P, Braun O, Van de Heyning CM, Montero S, Petrella D, Huang F, Schmidt M, Raineri C, Lala A, Varrenti M, Foa` A, Leone O, Gentile P, Artico J, Agostini V, Patel R, Garascia A, Van Craenenbroeck EM, Hirose K, Isotani A, Murohara T, Arita Y, Sionis A, Fabris E, Hashem S, Garcia-Hernando V, Oliva F, Greenberg B, MD, Shimokawa H, Sinagra G, Adler ED, Frigerio M, Camici PG. Viral genome search in myocardium of patients with fulminant myocarditis. Eur J Heart Fail. 22:1277-1280,2020. (IF=11.627)

  2. Yamanaka S, Sakata Y, Nochioka K, Miura M, Kasahara S, Sato M, Aoyanagi H, Fujihashi T, Hayashi H, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H. Prognostic impacts of dynamic cardiac structural changes in heart failure patients with preserved left ventricular ejection fraction. Eur J Heart Fail. 22:2258-2268,2020. (IF=11.627)

  3. Yaoita N, Satoh K, Satoh T, Shimizu T, Saito S, Sugimura K, Tatebe S, Yamamoto S, Aoki T, Kikuchi N, Kurosawa R, Miyata S, Nagasaki M, Yasuda J, Shimokawa H. Identification of the novel variants in patients with chronic thromboembolic pulmonary hypertension. J Am Heart Assoc. 2020;9:e015902. doi:10.1161/JAHA.120.015902 (IF=4.605)

  4. Mori H, Takahashi J, Sato K, Miyata S, Takagi Y, Tsunoda R, Sumiyoshi T, Matsui M, Tanabe Y, Sueda S, Momomura S, Kaikita K, Yasuda S, Ogawa H, Shimokawa H, Suzuki H, on behalf of the Japanese Coronary Spasm Association. The impact of antiplatelet therapy on patients with vasospastic angina: A multicenter registry study of the Japanese Coronary Spasm Association. Int J Cardiol Heart Vasc. https://doi.org/10.1016/j.ijcha.2020.100561

  5. Wakayama Y, Nakano M, Fukuda K, Kumagai K, Sugai Y, Hirose M, Yamaguchi N, Kondo M, Kaneta T, Fukuda H, Kagaya Y, Shimokawa H. Cardiac Resynchronization Therapy for Improving Non-Uniform Thickening of Left Ventricular Wall: Assessment by Quantitative Gated Myocardial Perfusion SPECT Tohoku J Exp Med. 251:69-79,2020. (IF=1.441)

  6. Sato M, Sakata Y, Sato K, Nochioka K, Miura M, Abe R, Oikawa T, Kasahara S, Aoyanagi H, Yamanaka S, Fujihashi T, Hayashi H, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H. Clinical characteristics and prognostic factors in elderly patients with chronic heart failure -A report from the CHART-2 Study- Int J Cardiol Heart Vasc. 2020 Mar 20;27:100497. doi: 10.1016/j.ijcha.2020.100497.

  7. Ohura-Kajitani S, Shiroto T, Godo S, Ikumi Y, Ito A, Sato K, Sugisawa J, Tsuchiya S, Suda A, Shindo T, Ikeda S, Hao K, Kikuchi Y, Nochioka K, Matsumoto Y, Takahashi J, Miyata S, Shimokawa H. Marked impairment of endothelium-dependent digital vasodilatations in patients with microvascular angina. - Evidence for systemic small artery disease - Arterioscler Thromb Vasc Biol. 40:1400-1412,2020. (IF=6.604)（4月16日プレスリリース）

  8. Matsuda M, Kanno H, Sugaya T, Yamaya S, Yahata K, Handa K, Shindo T, Shimokawa H, Ozawa H, Itoi E. Low-energy extracorporeal shock wave therapy promotes BDNF expression and improves functional recovery after spinal cord injury in rats. Exp Neurol. 2020 Jun;328:113251. doi: 10.1016/j.expneurol.2020.113251. (IF=4.691)

  9. Aoyanagi H, Nochioka K, Sakata Y, Miura M, Shiroto T, Abe R, Kasahara S, Sato M, Fujihashi T, Yamanaka S, Hayashi H, Sugimura K, Takahashi J, Miyata S, Shimokawa H. Temporal changes in left ventricular ejection fraction and their prognostic impacts in patients with Stage B heart failure. Int J Cardiol. 306:123-132,2020. (IF=3.229)

  10. Takada T, Sakata Y, Nochioka K, Miura M, Abe R, Kasahara S, Sato M, Aoyanagi H, Fujihashi T, Yamanaka S, Kota Suzuki K, ShirotoT, Sugimura K, Takahashi J, Miyata S, Shimokawa H. Risk of de-novo heart failure and competing risk in asymptomatic patients with structural heart diseases. Int J Cardiol. 307:87-93,2020. (IF=3.229)

  11. Ujiie N, Nakano T, Yamada M, Sato C, Nakanishi C, Fujishima F, Ito K, Shindo T, Shimokawa H, Kamei T. Low-energy extracorporeal shock wave therapy for a model of liver cirrhosis ameliorates liver fibrosis and liver function. Sci Rep. 10,2405,2020. (IF=3.998)

  12. Tsuchiya S, Matsumoto Y, Suzuki H, Takanami K, Kikuchi Y, Takahashi J, Miyata S, Tomita N, Kumaga K, Taki Y, Saiki Y, Arai H, Shimokawa H. Transcatheter aortic valve implantation improves cognitive function associated with increased cerebral blood flow in elderly patients with severe aortic stenosis. Eurointervention. 15(18):e1580-e1587,2020. (IF=3.993)

  13. Tadaki S, Sakata Y, Miura Y, Nochioka K, Miura M, Miyata S, Asakura M, Shimada K, Yamamoto T, Fukumoto Y, Kadokami T, Yasuda S, Miura T, Ando S, Yano M, Kitakaze M, Daida H, Shimokawa H. Factors limiting habitual exercise in patients with chronic heart failure: A multicenter prospective cohort study Heart Vessels. 35:655-664,2020.（IF=1.618）

  14. Sato K, Takahashi J, Hao K, Miyata S, Suda A, Shindo T, Ikeda S, Kikuchi Y, Shiroto T, Matsumoto Y, Sakata Y, Shimokawa H. Temporal trends in the prevalence and outcomes of geriatric patients with acute myocardial infarction in Japan -A report from with the Miyagi AMI Registry Study- J Cardiol. 75:465-472,2020. (IF=2.246)

  15. Suzuki H, Matsumoto Y, Sugimura K, Takahashi J, Miyata S, Fukumoto Y, Taki Y, Shimokawa H. Impacts of hippocampal blood flow on changes in left ventricular wall thickness in patients with chronic heart failure. Int J Cardiol. 310:103-107,2020. (IF=3.229)

  16. Shiroto T, Sakata Y, Nochioka K, Abe R, Kasahara S, Sato M, Aoyanagi H, Fujihashi T, Yamanaka S, Hayashi H, Miura M, Takahashi J, Miyata S, Shimokawa H. Clinical benefits and risks of antithrombotic therapy in patients with atrial fibrillation with comorbidities -A report from the CHART-2 Study- Int J Cardiol. 299:160-168,2020. (IF=3.229)

  17. Chiba T, Nakano M, Hasebe Y, Kimura Y, Fukasawa K, Miki K, Morosawa S, Takanami K, Ohta H, Fukuda K; Shimokawa H. Prognostic significance of left ventricular ejection fraction relevant to myocardial damage in patients with cardiac sarcoidosis. J Cardiol. 75:34-41,2020. (IF=2.246)

  18. Kanazawa M, Matsumoto Y, Takahashi K, Suzuki H, Uzuka H, Nishimiya K, Shimokawa H. Treadmill exercise prevents reduction of bone mineral density after myocardial infarction in apolipoprotein E-deficient mice. Eur J Prevent Cardiol. 27:28-35,2020. (IF=5.864)

  19. Ikumi Y, Shiroto T, Godo S, Saito H, Tanaka S, Ito A, Kajitani S, Monma Y, Miyata S, Tsutsui M, Shimokawa H. Important roles of endothelium-dependent hyperpolarization in coronary microcirculation and cardiac diastolic function in mice. J Cardiovasc Pharmacol. 75:31-40,2020. (IF=2.598)

  20. Kozu K, Satoh K, Aoki T, Tatebe S, Miura M, Yamamoto S, Yaoita N, Suzuki H, Shimizu T, Sato H, Konno R, Terui Y, Nochioka K, Kikuchi N, Satoh T, Sugimura K, Miyata S, Shimokawa H. Cyclophilin A as a biomarker for the therapeutic effect of balloon angioplasty in chronic thromboembolic pulmonary hypertension. J Cardiol. 75:415-423,2020. (IF=2.246)

  21. Kozu K, Sugimura K, Ito M, Hirata K, Node K, Miyamoto T, Ueno S, Watanabe H, Shimokawa H. Current status of long-term prognosis among all subtypes of pulmonary hypertension in Japan. Int J Cardiol. 300:228-235,2020. (IF=3.229)

  22. Nishizawa H, Matsumoto M, Shindo T, Saigusa D, Kato H, Suzuki K, Sato M, Ishii Y, Shimokawa H, Igarashi K. Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1. J Biol Chem. 295:69-82,2020. (IF=4.238)

  23. Kondo M, Fukuda K, Wakayama Y, Nakano M, Hasebe Y, Satake H, Segawa M, Hirano M, Shimokawa H. Different characteristics of postoperative atrial tachyarrhythmias between congenital and non-congenital heart disease. J Interv Card Electrophysiol. 58:1-8,2020 (IF=1.277)

  24. Akizuki M, Sugimura K, Aoki T, Kakihana T, Tatebe S, Yamamoto S, Sato H, Satoh K, Shimokawa H, Kohzuki M. Non-invasive screening using ventilatory gas analysis for distinguishing between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. Respirology. 25:427-434,2020. (IF=4.880)（2019年7月3日プレスリリース）